Trial Profile
A randomised, double-blind, placebo-controlled, within-subject crossover study investigating the effects of amisulpride and reboxetine on sexual stimulus processing in healthy males
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary) ; Reboxetine (Primary)
- Indications Major depressive disorder; Schizophrenia
- Focus Adverse reactions
- 30 Nov 2015 New trial record